Cristy C. Verzijl

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

VPS35 controls hepatocellular proliferation through SRC signalling and promotes diethyl nitrosamine-induced tumor initiation.

VPS35 controls hepatocellular proliferation through SRC signalling and promotes diethyl nitrosamine-induced tumor initiation.

Journal: Cellular and molecular gastroenterology and hepatology

Published: September 20, 2025

Vacuolar Protein Sorting 35 Controls Hepatocellular Proliferation Through SRC Signaling and Promotes Diethyl Nitrosamine-Induced Tumor Initiation.

Vacuolar Protein Sorting 35 Controls Hepatocellular Proliferation Through SRC Signaling and Promotes Diethyl Nitrosamine-Induced Tumor Initiation.

Journal: Cellular and molecular gastroenterology and hepatology

Published: September 20, 2025

Loss of Early Growth Response Protein 1 in the Liver Leads to Hepatic Lipid Accumulation Driven by an Imbalance Between Fatty Acid β-Oxidation and Oxidative Phosphorylation.

Loss of Early Growth Response Protein 1 in the Liver Leads to Hepatic Lipid Accumulation Driven by an Imbalance Between Fatty Acid β-Oxidation and Oxidative Phosphorylation.

Journal: Gastro hep advances

Published: June 04, 2025

Beta-Klotho Protein Expression in Healthy Human Tissues and Liver Biopsies From Patients With MASLD or MASH.

Beta-Klotho Protein Expression in Healthy Human Tissues and Liver Biopsies From Patients With MASLD or MASH.

Journal: Gastro hep advances

Published: March 26, 2025

Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho.

Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho.

Journal: Frontiers in endocrinology

Published: January 23, 2023

Pharmacological inhibition of MEK1/2 signaling disrupts bile acid metabolism through loss of Shp and enhanced Cyp7a1 expression.

Pharmacological inhibition of MEK1/2 signaling disrupts bile acid metabolism through loss of Shp and enhanced Cyp7a1 expression.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 02, 2022

Identification of an alternative triglyceride biosynthesis pathway.

Identification of an alternative triglyceride biosynthesis pathway.

Journal: Nature

Published: November 18, 2021

A novel role for GalNAc-T2 dependent glycosylation in energy homeostasis.

A novel role for GalNAc-T2 dependent glycosylation in energy homeostasis.

Journal: Molecular metabolism

Published: October 08, 2021

A physiological glucocorticoid rhythm is an important regulator of brown adipose tissue function.

A physiological glucocorticoid rhythm is an important regulator of brown adipose tissue function.

Journal: Molecular metabolism

Published: December 11, 2020

Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis.

Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis.

Journal: Expert opinion on investigational drugs

Published: January 05, 2020

Generation of new hepatocyte-like in vitro models better resembling human lipid metabolism.

Generation of new hepatocyte-like in vitro models better resembling human lipid metabolism.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: December 04, 2019

Selective Glucocorticoid Receptor Antagonist CORT125281 Activates Brown Adipose Tissue and Alters Lipid Distribution in Male Mice.

Selective Glucocorticoid Receptor Antagonist CORT125281 Activates Brown Adipose Tissue and Alters Lipid Distribution in Male Mice.

Journal: Endocrinology

Published: June 06, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026